Page last updated: 2024-10-31

methylphenidate and Heart Diseases

methylphenidate has been researched along with Heart Diseases in 3 studies

Methylphenidate: A central nervous system stimulant used most commonly in the treatment of ATTENTION DEFICIT DISORDER in children and for NARCOLEPSY. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. The d-isomer of this drug is referred to as DEXMETHYLPHENIDATE HYDROCHLORIDE.
methylphenidate : A racemate comprising equimolar amounts of the two threo isomers of methyl phenyl(piperidin-2-yl)acetate. A central stimulant and indirect-acting sympathomimetic, is used (generally as the hydrochloride salt) in the treatment of hyperactivity disorders in children and for the treatment of narcolepsy.
methyl phenyl(piperidin-2-yl)acetate : A amino acid ester that is methyl phenylacetate in which one of the hydrogens alpha to the carbonyl group is replaced by a piperidin-2-yl group.

Heart Diseases: Pathological conditions involving the HEART including its structural and functional abnormalities.

Research Excerpts

ExcerptRelevanceReference
" Despite their efficacy and long history of use, there is concern about their potential for adverse cardiovascular effects in children and adolescents."1.36Cardiovascular safety of stimulant medications for pediatric attention-deficit hyperactivity disorder. ( Muniz, R; Silva, RR; Skimming, JW, 2010)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Silva, RR1
Skimming, JW1
Muniz, R1
Kaufmann, MW1
Cassem, N1
Murray, G1
MacDonald, D1

Other Studies

3 other studies available for methylphenidate and Heart Diseases

ArticleYear
Cardiovascular safety of stimulant medications for pediatric attention-deficit hyperactivity disorder.
    Clinical pediatrics, 2010, Volume: 49, Issue:9

    Topics: Adolescent; Adult; Amphetamines; Attention Deficit Disorder with Hyperactivity; Blood Pressure; Card

2010
Methylphenidate: cardiac risks.
    Prescrire international, 2006, Volume: 15, Issue:84

    Topics: Central Nervous System Stimulants; Heart Diseases; Humans; Methylphenidate; Mortality

2006
The use of methylphenidate in depressed patients after cardiac surgery.
    The Journal of clinical psychiatry, 1984, Volume: 45, Issue:2

    Topics: Aged; Depressive Disorder; Female; Heart Diseases; Humans; Male; Methylphenidate; Middle Aged; Posto

1984